Invention Grant
- Patent Title: Exosome-based anticancer agent
-
Application No.: US16475052Application Date: 2017-12-29
-
Publication No.: US11319360B2Publication Date: 2022-05-03
- Inventor: Eun-ee Koh , Eun Jung Lee , Yoo Soo Yang , In-San Kim
- Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Seoul
- Agency: United One Law Group LLC
- Agent Kongsik Kim; Jhongwoo Peck
- Priority: KR10-2016-0182573 20161229
- International Application: PCT/KR2017/015784 WO 20171229
- International Announcement: WO2018/124835 WO 20180705
- Main IPC: C07K14/71
- IPC: C07K14/71 ; A61P35/00 ; C12N9/12 ; A61K38/00
Abstract:
The present invention provides a recombinant exosome and uses thereof. More particularly, the present invention provides a recombinant exosome wherein a phagocytosis promoting protein is presented on the surface thereof.
Public/Granted literature
- US20200148746A1 NOVEL EXOSOME-BASED ANTICANCER AGENT Public/Granted day:2020-05-14
Information query
